Communicating risks during pregnancy: A workshop on the use of data from animal developmental toxicity studies in pregnancy labels for drugs
- 12 January 2004
- journal article
- research article
- Published by Wiley in Birth Defects Research Part A: Clinical and Molecular Teratology
- Vol. 70 (1), 7-12
- https://doi.org/10.1002/bdra.10150
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Teratogenicity of recently introduced medications in human pregnancyPublished by Ovid Technologies (Wolters Kluwer Health) ,2002
- Review of pregnancy labeling of prescription drugs: Is the current system adequate to inform of risks?American Journal of Obstetrics and Gynecology, 2002
- Risk management strategies in the Physicians' Desk Reference product labels for pregnancy category X drugs.Drug Safety, 2002
- FDA Labeling System for Drugs in PregnancyAnnals of Pharmacotherapy, 2001
- Drug use during pregnancyThe Lancet, 2001
- Risk Classification Systems for Drug Use During PregnancyDrug Safety, 2000
- Classification of drugs for teratogenic riskEuropean Journal of Clinical Pharmacology, 1995
- FDA classification of drugs for teratogenic risk: Teratology society public affairs committeeTeratology, 1994
- Report of the Teratology Society Public Affairs Committee symposium on FDA classification of drugsTeratology, 1993